Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Correction

Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events

Authors: Ralph Rogers, Kapil Saharia, Aditya Chandorkar, Zoe F. Weiss, Kendra Vieira, Sophia Koo, Dimitrios Farmakiotis

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Excerpt

Correction to: BMC Infectious Diseases (2020) 20:58.
Literature
1.
go back to reference Rogers et al. Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events. BMC Infectious Diseases (2020) 20:58, doi: https://doi.org/10.1186/s12879-020-4787-4 Rogers et al. Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events. BMC Infectious Diseases (2020) 20:58, doi: https://​doi.​org/​10.​1186/​s12879-020-4787-4
Metadata
Title
Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Authors
Ralph Rogers
Kapil Saharia
Aditya Chandorkar
Zoe F. Weiss
Kendra Vieira
Sophia Koo
Dimitrios Farmakiotis
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-4848-8

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue